This webinar will explore why reimbursement strategy must be embedded early in product development, not bolted on after approval. We’ll break down:

• The difference between regulatory clearance and payer coverage

• How coding, DRG assignment, and payment mechanisms impact commercial viability

• The financial risks of delaying reimbursement planning

• How early payer engagement can de-risk investment and strengthen valuation

• Practical steps startups can take in the pre-clinical and clinical phases to build a reimbursement-ready evidence strategy